Your browser doesn't support javascript.
loading
Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities.
Wojcik, Monica H; Schwartz, Talia S; Yamin, Inbar; Edward, Heather L; Genetti, Casie A; Towne, Meghan C; Agrawal, Pankaj B.
Afiliação
  • Wojcik MH; Division of Newborn Medicine, Harvard Medical School, Boston, Massachusetts, USA. Monica.Wojcik@childrens.harvard.edu.
  • Schwartz TS; Division of Genetics and Genomics, Harvard Medical School, Boston, Massachusetts, USA. Monica.Wojcik@childrens.harvard.edu.
  • Yamin I; The Manton Center for Orphan Disease Research, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Monica.Wojcik@childrens.harvard.edu.
  • Edward HL; Division of Genetics and Genomics, Harvard Medical School, Boston, Massachusetts, USA.
  • Genetti CA; The Manton Center for Orphan Disease Research, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Towne MC; Division of Genetics and Genomics, Harvard Medical School, Boston, Massachusetts, USA.
  • Agrawal PB; The Manton Center for Orphan Disease Research, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Genet Med ; 20(11): 1396-1404, 2018 11.
Article em En | MEDLINE | ID: mdl-29790870
PURPOSE: Infants admitted to a level IV neonatal intensive care unit (NICU) who do not survive early childhood are a population that is probably enriched for rare genetic disease; we therefore characterized their genetic diagnostic evaluation. METHODS: This is a retrospective analysis of infants admitted to our NICU between 1 January 2011 and 31 December 2015 who were deceased at the time of records review, with age at death less than 5 years. RESULTS: A total of 2,670 infants were admitted; 170 later died. One hundred six of 170 (62%) had an evaluation for a genetic or metabolic disorder. Forty-seven of 170 (28%) had laboratory-confirmed genetic diagnoses, although 14/47 (30%) diagnoses were made postmortem. Infants evaluated for a genetic disorder spent more time in the NICU (median 13.5 vs. 5.0 days; p = 0.003), were older at death (median 92.0 vs. 17.5 days; p < 0.001), and had similarly high rates of redirection of care (86% vs. 79%; p = 0.28). CONCLUSION: Genetic disorders were suspected in many infants but found in a minority. Approximately one-third of diagnosed infants died before a laboratory-confirmed genetic diagnosis was made. This highlights the need to improve genetic diagnostic evaluation in the NICU, particularly to support end-of-life decision making.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mortalidade Infantil / Diagnóstico Tardio / Doenças Genéticas Inatas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mortalidade Infantil / Diagnóstico Tardio / Doenças Genéticas Inatas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos